Hearst has put $75m into M2Gen, a genetic database subsidiary of Moffitt Cancer Center, with a view to accelerating the development of cancer treatments.

The cardiovascular software developer has built modelling programs that could help doctors decide whether patients are fit for surgery.

University of Pittsburgh and accelerator BioMotiv are set to generate a spinout based on anti-inflammatory research by Rama Mallampalli and Beibei Chen.

Vertera Spine, a spinal implant developer base on Duke and Georgia Tech research, has been picked up shortly after receiving regulatory approval for two products.

The neurological disorder drug developer has secured $20m in a series B round backed by existing investors Johnson and Johnson and WuXi AppTec.

Diabetes treatment spinout Alms Therapeutics signed up Cap Innov'Est and Morningside Venture Capital as investors after previously tapping regional tech transfer office Satt Conectus for funding.

Legend Capital co-led the pharmaceutical and chemical research service provider's series B round, which also featured Dianjing Shijie.

Multi-university venturing fund Uniseed has invested $500,000 in smartphone cardiac monitoring developer Cardihab.